Results 111 to 120 of about 94,546 (247)

PIH7 BURDEN OF ILLNESS OF HYPERTENSION AMONG WOMEN USING MENOPAUSAL HORMONE THERAPY

, 2008
EM Pelletier, JA Gricar, Pik‐Eu Chang, GG Nahum, Rajeshwari Mittapally   +4 more
openalex   +1 more source

SSRI & SNRI over Menopausal Hormone Therapy (MHT) - Would be more practical to initiate due to its free availability and affordable price under this economic crisis of Sri Lanka [PDF]

, 2023
D. Somirathne
openalex   +1 more source

The relationship of hand osteoarthritis symptom onset with menopause and menopausal hormonal therapy-results of a retrospective secondary care study [PDF]

, 2021
Fiona E. Watt, Malvika Gulati, Gretchen Brewer, Andrew Judge, Donna L. Kennedy, Tonia L. Vincent   +5 more
openalex   +1 more source

Menopausal hormone therapy and dementia: nationwide, nested case-control study [PDF]

, 2023
Nelsan Pourhadi, Lina Steinrud Mørch, Ellen Holm, Christian Torp‐Pedersen, Amani Meaidi   +4 more
openalex   +1 more source

Choroba zakrzepowo-zatorowa w okresie menopauzalnym

Menopause Review, 2010
Venous thromboembolism (VTE) is treated shabbily in gynaecology of the menopausal period. Being a seriouscomplication of neoplasms, operative procedures and – at last – menopausal hormone therapy (MHT), it isundoubtedly noteworthy and calls for in-depth ...
Grzegorz Stachowiak, Tomasz Stetkiewicz
doaj  

[Menopausal hormone therapy].

Arquivos brasileiros de endocrinologia e metabologia, 2009
Although estrogen has been clinically available for more than 6 decades, women have been confused by different opinions regarding the risks and benefits of menopausal hormone therapy (HT), estrogen therapy (ET), and estrogen-progestin therapy (EPT).
openaire   +1 more source

A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density [PDF]

, 2015
Anja Rudolph, Peter A. Fasching, Sabine Behrens, Ursula Eilber, Manjeet K. Bolla, Qin Wang, Deborah J. Thompson, Kamila Czene, Judith S. Brand, Jingmei Li, Christopher G. Scott, V. Shane Pankratz, Kathleen R. Brandt, Emily Hallberg, Janet E. Olson, Adam Lee, Matthias W. Beckmann, Arif B. Ekici, Lothar Haeberle, Gertraud Maskarinec, Loı̈c Le Marchand, Fredrick R. Schumacher, Roger L. Milne, Julia A. Knight, Carmel Apicella, Melissa C. Southey, Miroslav Kapuscinski, John L. Hopper, Irene L. Andrulis, Graham G. Giles, Christopher A. Haiman, Kay‐Tee Khaw, Robert Luben, Per Hall, Paul D.P. Pharoah, Fergus J. Couch, Douglas F. Easton, Isabel dos‐Santos‐Silva, Celine M. Vachon, Jenny Chang‐Claude   +39 more
openalex   +1 more source

Preliminary Cost Variance Modeling to Compare Autologous Intraovarian Platelet-Rich Plasma vs. Standard Hormone Replacement Therapy for Menopause Management

, 2021
E. Scott Sills, Seang Lin Tan
openalex   +2 more sources

Menopause hormone therapy and complementary alternative medicine, quality of life, and racial/ethnic differences: the Study of Women's Health Across the Nation (SWAN)

, 2022
Monica Christmas, İmke Janssen, Hadine Joffe, Dawn M. Upchurch, Nanette Santoro, Howard M. Kravitz   +5 more
openalex   +2 more sources

Kliniczne aspekty atrofii urogenitalnej u kobiet

Menopause Review, 2011
Female urogenital atrophy increases with the menopausal age. It is also susceptible to various types ofhormonal therapy, e.g. systemic menopausal hormonal therapy and vaginal hormone therapy.
Grzegorz Stachowiak, Tomasz Pertyński
doaj